1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
GelStat Corporation

GelStat Corporation

GSAC
GelStat CorporationUS flagOther OTC
0.00
USD
+0.00
- -
123,596.00Market Cap
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
TTM
Revenue per Share
1.83
0.86
0.72
0.48
0.02
- -
- -
- -
0.02
0.02
0.01
- -
- -
- -
Basic EPS, GAAP
-0.06
0.18
-0.08
-0.81
-0.25
-0.03
0.33
-0.22
-0.56
-0.41
-0.1
-0.04
- -
-0.02
Free Cash Flow per Basic Share
-0.3
0.05
-0.08
0.08
-0.1
-0.04
-0.08
-0.19
-0.52
-0.14
-0.03
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.75
-0.96
-1.58
-2.4
-2.35
-1.85
-0.03
-0.23
-0.7
-0.94
-0.83
-0.65
- -
-0.57
Tangible Book Value per Share
0.47
0.42
0.87
0.19
-0.02
-0.06
-0.04
0.13
0.1
-0.09
-0.09
-0.08
- -
-0.08
Basic Weighted Avg Shares
3
4
2
2
3
4
4
7
11
14
18
25
- -
29
Sales/Revenue/Turnover
5
3
2
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
3.93
15.99
-0.14
-5.44
-864.44
-6,329.65
- -
- -
-2,398.02
-1,099.24
-752.7
-5,722.42
-1,815.11
-1,815.04
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
1
- -
-2
-1
- -
1
-1
-6
-6
-2
-1
- -
- -
Effective Tax Rate (%)
53.62
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-3.41
21.46
-10.65
-170.47
-1,426.15
-3,835.62
- -
- -
-2,541.55
-1,713.42
-776.94
-5,960.31
-2,011.73
-2,011.64
Working Capital
1
1
1
- -
- -
- -
- -
1
1
-1
-2
-2
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
2
2
- -
- -
- -
- -
1
1
-1
-2
-2
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-15.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'08
Sep'08
Dec'08
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
36
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Jun'08
Sep'08
Dec'08
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
2
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-77.03%
-22.6%
11.11%
Free Cash Flow
2.27%
18.28%
-47.82%
Net Income, GAAP
-59.73%
29.85%
-57.26%
Sales/Revenue/Turnover
- -
1,572.86%
26.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.04
-0.02
-0.02
- -
-0.1
2007
-0.01
-0.01
-0.01
- -
-0.04
2008
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Javier G. Acosta
Full Time Employees
2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3557 SW Corporate Parkway Palm City FL United States of America 34990
IPO Date
Feb 9, 1996
CIK
0000890725
Website
gelstat.com
Similar Companies
PT Tempo Scan Pacific Tbk (TSPC.JK)
Sofgen Pharma S.A. (PRCWF)
The Greater Cannabis Company, Inc. (GCAN)
Koa Shoji Holdings Co.,Ltd. (9273.T)
Bakhu Holdings, Corp. (BKUH)
Ilyang Pharmaceutical Co.,Ltd (007570.KS)
Business
GelStat Corporation (OTC: GSAC) develops and markets innovative gel-based nutritional and wellness products targeting digestive health, pain relief, and sleep support. The company offers GelTabs, a proprietary delivery system utilizing advanced gel matrix technology for rapid absorption; core products include Lidtke GelStat Migraine Relief for fast-acting migraine symptom alleviation, GelStat Migraine but without caffeine, GelStat Sleep for natural sleep aid, and GelStat Ultra Pain Relief for joint and muscle discomfort. These products are distributed through retail channels, e-commerce platforms, and healthcare providers in the United States. Founded in 2002 and headquartered in Duluth, Georgia, GelStat operates primarily in the consumer health and nutraceuticals segment, serving individual consumers seeking non-pharmaceutical alternatives. In recent developments, the company has focused on expanding its product pipeline and distribution partnerships within the last two years, including enhanced marketing alliances with major retailers to broaden accessibility of its GelTabs line.

Company News

APIChat

  • globenewswire.com

    GSAC Engineering Secures Multi-Year Recurring Revenue Contract

  • globenewswire.com

    GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group